Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
15
pubmed:dateCreated
2006-4-10
pubmed:abstractText
To examine whether globotriaosylceramide (Gb3/CD77) is a receptor for verotoxins (VTs) in vivo, sensitivity of Gb3/CD77 synthase null mutant mice to VT-2 and VT-1 was analyzed. Although wild-type mice died after administration of 0.02 microg of VT-2 or 1.0 microg of VT-1, the mutant mice showed no reaction to doses as much as 100 times that administered to wild types. Expression analysis of Gb3/CD77 in mouse tissues with antibody revealed that low, but definite, levels of Gb3/CD77 were expressed in the microvascular endothelial cells of the brain cortex and pia mater and in renal tubular capillaries. Corresponding to the Gb3/CD77 expression, tissue damage with edema, congestion, and cytopathic changes was observed, indicating that Gb3/CD77 (and its derivatives) exclusively function as a receptor for VTs in vivo. The lethal kinetics were similar regardless of lipopolysaccharide elimination in VT preparation, suggesting that basal Gb3/CD77 levels are sufficient for lethal effects of VTs.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
14
pubmed:volume
281
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
10230-5
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16476743-Animals, pubmed-meshheading:16476743-Blotting, Northern, pubmed-meshheading:16476743-Blotting, Southern, pubmed-meshheading:16476743-Brain, pubmed-meshheading:16476743-Chromatography, Thin Layer, pubmed-meshheading:16476743-Cytokines, pubmed-meshheading:16476743-Escherichia coli, pubmed-meshheading:16476743-Female, pubmed-meshheading:16476743-Galactosyltransferases, pubmed-meshheading:16476743-Gene Deletion, pubmed-meshheading:16476743-Gene Expression Regulation, pubmed-meshheading:16476743-Gene Expression Regulation, Enzymologic, pubmed-meshheading:16476743-Genetic Vectors, pubmed-meshheading:16476743-Glycolipids, pubmed-meshheading:16476743-Glycosphingolipids, pubmed-meshheading:16476743-Immunohistochemistry, pubmed-meshheading:16476743-Inflammation, pubmed-meshheading:16476743-Interleukin-1, pubmed-meshheading:16476743-Kidney, pubmed-meshheading:16476743-Kidney Tubules, pubmed-meshheading:16476743-Kinetics, pubmed-meshheading:16476743-Lipopolysaccharides, pubmed-meshheading:16476743-Lymphocytes, pubmed-meshheading:16476743-Male, pubmed-meshheading:16476743-Mice, pubmed-meshheading:16476743-Mice, Knockout, pubmed-meshheading:16476743-Microcirculation, pubmed-meshheading:16476743-Models, Genetic, pubmed-meshheading:16476743-Mutation, pubmed-meshheading:16476743-Recombination, Genetic, pubmed-meshheading:16476743-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:16476743-Shiga Toxins, pubmed-meshheading:16476743-Time Factors, pubmed-meshheading:16476743-Tumor Necrosis Factor-alpha
pubmed:year
2006
pubmed:articleTitle
Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins.
pubmed:affiliation
Department of Biochemistry II, Nagoya University School of Medicine, Tsurumai, Showa-ku, Nagoya 466-0065, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't